These cumulative observations suggest PPARα agonism will manifest pleiotropic downstream effects such as anti-apoptosis, anti-inflammation, and anti-oxidation—all of which would be beneficial to addressing the complex nature of prevalent retinal diseases. The gene discussed is PPARA; the disease is Abnormal retinal morphology.